OncoSwab
1 known investors
Find your way into OncoSwab
Sign up to see every warm intro you have to OncoSwab
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OncoSwab team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OncoSwab develops a nasal swab-based sampling platform that captures airway-derived genetic material to detect ctDNA and cancer-associated biomarkers at the origin of lung cancer, complementing blood-based liquid biopsy. It is offered as a Research Use Only tool for researchers running lung cancer biomarker, longitudinal, and multi-site studies while clinical validation is underway.
Investors · 1
Frequently asked questions
- What does OncoSwab do?
- OncoSwab develops a nasal swab-based sampling platform that captures airway-derived genetic material to detect ctDNA and cancer-associated biomarkers at the origin of lung cancer, complementing blood-based liquid biopsy. It is offered as a Research Use Only tool for researchers running lung cancer biomarker, longitudinal, and multi-site studies while clinical validation is underway.
- Who are OncoSwab's investors?
- OncoSwab's investors include Health Wildcatters.
